🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

5+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 5 of 5 recruiting trials for “Malignant non-epithelial tumor of ovary”

Phase 1, PHASE2RecruitingNCT07189871 ↗

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

🏥 Radiopharm Theranostics, Ltd📍 4 sites📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07216105 ↗

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

👨‍⚕️ Brian Dempster, Fate Therapeutics📍 3 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT06238479 ↗

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

👨‍⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 28 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT05872204 ↗

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

👨‍⚕️ Els Van Nieuwenhuysen, MD PhD, UZ Leuven📍 12 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT04644289 ↗

WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC

👨‍⚕️ Frederik Marmé, MD, Universitätsklinikum Mannheim, Frauenklinik📍 6 sites📅 Started May 2022View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →